- Report
- May 2025
- 191 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- February 2025
Global
From €4439EUR$4,900USD£3,826GBP
- Report
- January 2025
- 142 Pages
Asia Pacific
From €2944EUR$3,250USD£2,538GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3080EUR$3,400USD£2,655GBP
€3624EUR$4,000USD£3,123GBP
- Report
- January 2025
- 768 Pages
Global
From €4347EUR$4,799USD£3,747GBP
- Report
- July 2025
Global
From €4525EUR$4,995USD£3,900GBP
- Report
- April 2025
- 140 Pages
Global
From €4439EUR$4,900USD£3,826GBP
- Report
- May 2025
- 188 Pages
Global
From €3211EUR$3,545USD£2,768GBP
€3568EUR$3,939USD£3,076GBP
- Report
- April 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- March 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- February 2025
- 200 Pages
Global
From €4067EUR$4,490USD£3,506GBP
- Report
- July 2025
- 287 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- July 2025
- 370 Pages
Global
From €5299EUR$5,850USD£4,568GBP
- Report
- August 2024
- 232 Pages
Global
From €4031EUR$4,450USD£3,475GBP
- Report
- June 2025
- 400 Pages
Global
From €4483EUR$4,949USD£3,864GBP
- Report
- April 2025
- 163 Pages
Europe
From €3125EUR$3,450USD£2,694GBP
- Report
- April 2025
- 161 Pages
Asia Pacific
From €3125EUR$3,450USD£2,694GBP
- Report
- April 2025
- 142 Pages
North America
From €3125EUR$3,450USD£2,694GBP

Cell and Gene Therapy Manufacturing is a rapidly growing field within the genomics industry. It involves the production of therapeutic cells and genes for use in medical treatments. This includes the production of stem cells, gene-modified cells, and gene-editing tools. The process involves the isolation, expansion, and differentiation of cells, as well as the production of gene-editing tools such as CRISPR-Cas9. The goal is to create therapeutic cells and genes that can be used to treat a variety of diseases.
Cell and Gene Therapy Manufacturing is a highly specialized field, requiring expertise in cell biology, molecular biology, and biochemistry. It also requires the use of advanced technologies such as gene-editing tools, cell culture systems, and bioreactors.
Companies in the Cell and Gene Therapy Manufacturing market include bluebird bio, Cellectis, CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics. These companies are focused on developing and manufacturing therapeutic cells and genes for use in medical treatments. Show Less Read more